skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8847

Changing the burden of COPD mortality

(2347) Views  (493) Full article downloads

Authors: David M Mannino, Victor A Kiri

Published Date May 2006 Volume 2006:1(3) Pages 219 - 233
DOI: http://dx.doi.org/10.2147/COPD.S

David M Mannino1, Victor A Kiri2

1University of Kentucky School of Medicine, Lexington, KY, USA; 2Worldwide Epidemiology, GlaxoSmithKline, Greenford, UK

Abstract: COPD is a major cause of mortality and morbidity worldwide with an estimated 2.75 million deaths in 2000 (fourth leading cause of death). In addition to the considerable morbidity and mortality associated with COPD, this disease incurs significant healthcare and societal costs. Current COPD guidelines acknowledge that the following can improve COPD mortality: smoking cessation; long-term oxygen therapy; and lung volume reduction surgery in small subsets of COPD patients. To date, no randomized controlled trials have demonstrated an effect of pharmacological treatment on mortality, although several observational studies suggest that both long-acting bronchodilators and inhaled corticosteroids may provide a survival benefit. The possibility that these treatments reduce mortality is being investigated in ongoing large-scale clinical trials.

Keywords: COPD, epidemiology, mortality, morbidity, treatment








Readers of this article also read:

Strategies for improving outcomes of COPD exacerbations
The severity of airways obstruction as a determinant of treatment response in COPD
Gamma knife radiosurgery for uveal melanoma ineligible for brachytherapy by the Collaborative Ocular Melanoma Study criteria
Chronic obstructive pulmonary disease as an independent risk factor for cardiovascular morbidity
A day at a time: caregiving on the edge in advanced COPD
Functional mobility and balance in community-dwelling elderly submitted to multisensory versus strength exercises
Fatigue in patients with COPD participating in a pulmonary rehabilitation program
COPD is frequent in conditions of comorbidity in patients treated with various diseases in a university hospital
Enucleation following treatment with intravenous pentamidine for Acanthamoeba sclerokeratitis
Lung function decline in COPD
  • Journal Indexing

    See where all the Dove Press journals are indexed

  • Testimonials

    "You do a tremendous job!!" Ruben Restrepo, The University of Texas Health Science Center at San Antonio